The Beauty Health Company Statistics
Total Valuation
SKIN has a market cap or net worth of $423.35 million. The enterprise value is $652.62 million.
| Market Cap | 423.35M |
| Enterprise Value | 652.62M |
Important Dates
The next estimated earnings date is Wednesday, May 8, 2024, before market open.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SKIN has 123.43 million shares outstanding. The number of shares has decreased by -11.33% in one year.
| Shares Outstanding | 123.43M |
| Shares Change (YoY) | -11.33% |
| Shares Change (QoQ) | -3.17% |
| Owned by Insiders (%) | 10.03% |
| Owned by Institutions (%) | 97.93% |
| Float | 70.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.06 |
| Forward PS | 1.04 |
| PB Ratio | 7.13 |
| P/FCF Ratio | 48.66 |
| PEG Ratio | 0.95 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 75.01 |
Financial Position
The company has a current ratio of 6.07, with a Debt / Equity ratio of 12.67.
| Current Ratio | 6.07 |
| Quick Ratio | 5.02 |
| Debt / Equity | 12.67 |
| Debt / EBITDA | n/a |
| Debt / FCF | 86.46 |
| Interest Coverage | -6.46 |
Financial Efficiency
Return on equity (ROE) is -87.30% and return on invested capital (ROIC) is -16.13%.
| Return on Equity (ROE) | -87.30% |
| Return on Assets (ROA) | -10.30% |
| Return on Capital (ROIC) | -16.13% |
| Revenue Per Employee | $451,749 |
| Profits Per Employee | -$113,639 |
| Employee Count | 881 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 2.42 |
Taxes
| Income Tax | -1.77M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -74.96% in the last 52 weeks. The beta is 1.02, so SKIN's price volatility has been similar to the market average.
| Beta (1Y) | 1.02 |
| 52-Week Price Change | -74.96% |
| 50-Day Moving Average | 3.60 |
| 200-Day Moving Average | 4.61 |
| Relative Strength Index (RSI) | 41.16 |
| Average Volume (30 Days) | 2,680,875 |
Short Selling Information
The latest short interest is 10.77 million, so 8.73% of the outstanding shares have been sold short.
| Short Interest | 10.77M |
| Short Previous Month | 12.00M |
| Short % of Shares Out | 8.73% |
| Short % of Float | 15.32% |
| Short Ratio (days to cover) | 2.87 |
Income Statement
In the last 12 months, SKIN had revenue of $397.99 million and -$100.12 million in losses. Loss per share was -$0.76.
| Revenue | 397.99M |
| Gross Profit | 155.11M |
| Operating Income | -130.92M |
| Pretax Income | -101.89M |
| Net Income | -100.12M |
| EBITDA | -53.57M |
| EBIT | -88.24M |
| Loss Per Share | -$0.76 |
Balance Sheet
The company has $523.03 million in cash and $752.29 million in debt, giving a net cash position of -$229.26 million or -$1.86 per share.
| Cash & Cash Equivalents | 523.03M |
| Total Debt | 752.29M |
| Net Cash | -229.26M |
| Net Cash Per Share | -$1.86 |
| Equity / Book Value | 59.39M |
| Book Value Per Share | 0.48 |
| Working Capital | 583.24M |
Cash Flow
In the last 12 months, operating cash flow was $21.75 million and capital expenditures -$13.05 million, giving a free cash flow of $8.70 million.
| Operating Cash Flow | 21.75M |
| Capital Expenditures | -13.05M |
| Free Cash Flow | 8.70M |
| FCF Per Share | $0.07 |
Margins
Gross margin is 38.97%, with operating and profit margins of -32.89% and -25.16%.
| Gross Margin | 38.97% |
| Operating Margin | -32.89% |
| Pretax Margin | -25.60% |
| Profit Margin | -25.16% |
| EBITDA Margin | -13.46% |
| EBIT Margin | -22.17% |
| FCF Margin | 2.19% |
Dividends & Yields
SKIN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 11.33% |
| Shareholder Yield | 11.33% |
| Earnings Yield | -23.65% |
| FCF Yield | 2.06% |
Analyst Forecast
The average price target for SKIN is $4.50, which is 31.20% higher than the current price. The consensus rating is "Hold".
| Price Target | $4.50 |
| Price Target Difference | 31.20% |
| Analyst Consensus | Hold |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 7.46% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SKIN has an Altman Z-Score of 0.44 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.44 |
| Piotroski F-Score | 4 |